ChemoCentryx
CCXI
#3634
Rank
NZ$6.21 B
Marketcap
NZ$86.46
Share price
0.00%
Change (1 day)
23.85%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): NZ-$2.81

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is NZ-$3.14. In 2021 the company made an earnings per share (EPS) of NZ-$3.14 a decrease over its 2020 EPS that were of NZ-$1.35.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.81-10.55%
2021NZ-$3.14133.33%
2020NZ-$1.35-16.49%
2019NZ-$1.6127.63%
2018NZ-$1.26-305.41%
2017NZ$0.62-142.53%
2016NZ-$1.45-19.44%
2015NZ-$1.80-0%
2014NZ-$1.8013.68%
2013NZ-$1.58-16.67%
2012NZ-$1.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.36-652.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.86-191.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.25-171.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.67-789.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.28-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.63-501.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.94-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.98-290.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.05-133.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel